June 2015 | 第 2 页，共 2 页 | Certara

Comparison of Non-linear PK Models for Filgrastim

2015 年 6 月 8 日

A Minimal Physiologically-based Pharmacokinetic Model of IgG: Impact of Inclusion of 2:1 FcRn IgG Binding Stoichiometry and a Proportion of CL That Is Independent of FcRn Binding

2015 年 6 月 8 日

Certara Endows Lectureship in Precision Dosing at The University of Manchester, England

2015 年 6 月 3 日

New academic collaboration will help to advance precision medicine efforts to deliver the right treatment to patients at the right time PRINCETON, NJ – 2015 年 6 月 3 日 – Certara®, the global biosimulation technology-enabled drug development consultancy, today announced that it is endowing a new three-year, full-time position – the Certara Lecturer in Precision Dosing – … Continued

Raltegravir Dosing in Neonates (IMPAACT P1110): Use of Allometry and Maturation in PK Modeling to Develop a Daily Dosing Regimen for Investigation During the First Weeks of Life

2015 年 6 月 2 日

Towards more Realistic Clinical Trial Simulation: Establishing Inter-correlations Between Several Cytochrome P450 Enzyme Abundances in Human Liver

2015 年 6 月 2 日

Emerging Covariates on the Pharmacokinetics of Monoclonal Antibodies: Do Current PBPK Models Account for the Significant Covariates Identified in PopPK Studies?

2015 年 6 月 2 日

Application of Simcyp’s R Library Package in Simulation and Prediction of Metoprolol Compliance Using a Single Plasma Concentration Sample

2015 年 6 月 2 日

Standardized Output (SO): Flexible and Tool-independent Storage Format of Typical M&S Results

2015 年 6 月 2 日

Extended Validation of a Peripheral Sampling Site in PBPK Modeling Using Clarithromycin, Dextromethorphan, Dextrorphan, Erythromycin, Lidocaine and Tramadol

2015 年 6 月 2 日

2 of 2

沪ICP备2022021526号

Powered by Translations.com GlobalLink OneLink Software